NCT04199299 Sensors for Communication for Persons Who Cannot Communicate Unequivocally
| NCT ID | NCT04199299 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oslo |
| Condition | Intellectual Disability |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-02-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2020-02-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Some persons with intellectual disability or comprehensive cerebral palsy cannot communicate unequivocally how they are, how they react to situations and people, whether they are in pain or experience discomfort, anger or fear. Their modes of communication (sounds, grimacing etc) may be unintelligible or ambiguous to their caregivers. With the use of heart and/or respiration monitors the investigators aim to give these persons a means to communicate their immediate reactions or responses. The respiration monitor is meant to register sleep at night, so that the participants can communicate whether they have slept well or not the previous night.
Eligibility Criteria
Inclusion Criteria: * intellectual disability with or without autism and/or cerebral palsy that render the participant unable to communicate his/her needs and reactions unequivocally. Exclusion Criteria: * allergic skin reaction to chest strap
Contact & Investigator
Bjørnar Hassel, PhD
PRINCIPAL INVESTIGATOR
University of Oslo
Frequently Asked Questions
Who can join the NCT04199299 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 80 Years, studying Intellectual Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04199299 currently recruiting?
Yes, NCT04199299 is actively recruiting participants. Contact the research team at bjornar.hassel@medisin.uio.no for enrollment information.
Where is the NCT04199299 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT04199299 clinical trial?
NCT04199299 is sponsored by University of Oslo. The principal investigator is Bjørnar Hassel, PhD at University of Oslo. The trial plans to enroll 100 participants.